Targeting CNS Disease with Gene Therapies
RARECast - A podcast by RARECast - Giovedì
Categorie:
Bruce Goldsmith, CEO of Passage Bio, discusses the company’s relationship with Penn’s Gene Therapy Program, its focus on CNS conditions, and the company’s lead program in the rare lysosomal storage disorder GM1 gangliosidosis.
